Navigation Links
Cempra Provides Guidance on the Clinical Program Required for Regulatory Approval for Solithromycin for Community-Acquired Bacterial Pneumonia (CABP)
Date:6/13/2013

rtainties that could cause the actual events or results to differ materially. These risks and uncertainties include, among others: the FDA's agreement with our planned studies and trials and the sufficiency of trial results to support a New Drug Application; the results, timing, costs and regulatory review of our studies and clinical trials; our need to obtain additional funding and our ability to obtain future funding on acceptable terms; regulatory rulemaking; our anticipated capital expenditures and our estimates regarding our capital requirements; the results of studies of our product candidates conducted by others; the possible impairment of, or inability to obtain, intellectual property rights and the costs of obtaining such rights from third parties; our ability to obtain FDA approval of our product candidates; our dependence on the success of solithromycin and Taksta; and innovation by our competitors. The reader is referred to the documents that we file from time to time with the Securities and Exchange Commission.

Investor Contacts:
Robert E. Flamm, Ph.D.
Russo Partners, LLC
(212) 845-4226 
Robert.flamm@russopartnersllc.com

Andreas Marathovouniotis
Russo Partners, LLC
(212) 845-4235
Andreas.marathis@russopartnersllc.com

Media Contact:
Karine Kleinhaus, M.D.
Russo Partners, LLC
(646) 942-5632
Karine.kleinhaus@russopartnersllc.com

 


'/>"/>
SOURCE Cempra, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cempra Presents Post-Phase 2 Analysis of Solithromycins Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP)
2. Cempra, Inc. Reports Fourth Quarter and Full Year 2012 Financial and Operating Results
3. Cempra Inc. Presents Additional Data on the Clinical Profile and Activity Spectrum of Solithromycin at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
4. The Hemostemix Group of Companies Provides Corporate Strategy Update
5. Study led by GW professor provides better understanding of waters freezing behavior at nanoscale
6. Yongye International Provides Update on Status of Proposed Go Private Offer
7. Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update
8. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2013 Financials
9. Celsion Corporation Reports First Quarter 2013 Financial Results and Provides Business Update
10. Adamis Pharmaceuticals CEO Provides Update for Shareholders
11. Cellular Biomedicine Group Provides Update and 2013 Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... March 26, 2015 PAREXEL International ... clinical research organization , announced today ... agreement to acquire all of the business ... leading provider of specialized pharmacovigilance services, based ... collection, detection, assessment, monitoring, and prevention of ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 "In America," the ... the United States that is hosted by legendary film actor ... topic of botany in an upcoming segment. , Botany ... in reality it is actually quite a bit more complicated ... of different types of living organisms, from the smallest bacteria ...
(Date:3/26/2015)... 26, 2015 WriteResult, a premier provider ... from Yale University’s School of Public Health and New ... during a 4 month-long project. The goal of the ... income families with free access to fresh produce and ... health concerns like high blood pressure, diabetes and weight ...
(Date:3/25/2015)... 2015 Agnition announced today that it ... Farmer, airing for the first time at 7:30 a.m. ... Farmer will explore the extremely important role soil microbes ... a patented Microbial Catalyst™ technology that enhances soil and ... segment will air again on April 28. , A ...
Breaking Biology Technology:PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 2PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 3PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 4Yale and New Haven Farms Improving Patient Health with WriteResult's myPROpad™ 2Yale and New Haven Farms Improving Patient Health with WriteResult's myPROpad™ 3Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2
... MS, EDMONTON, March 24 /PRNewswire-FirstCall/ - BioMS Medical ... multiple sclerosis (MS), today,announced that Mr. Kevin Giese, President ... the Biotech Industry" Conference in New York., ... Time), WHERE: The Millennium Broadway Hotel & ...
... 24 Finesse Solutions, LLC, a,manufacturer of measurement ... the release of TruFluor(TM), a single use optical,dissolved ... March,26, 2008., The TruFluor(TM) dissolved oxygen and ... disposable sheath, an optical reader,and a transmitter. The ...
... Martek Biosciences,(Nasdaq: MATK ) announced today the availability ... vegetarian form of DHA,omega-3 for brain, eye and heart ... mg per gram of life,sDHA and contains no soy ... applications where,allergens and labeling are concerns., "Our new ...
Cached Biology Technology:BioMS Medical to present at BioCentury Conference 2Finesse Introduces TruFluor(TM) DO, a Single-Use Optical Dissolved Oxygen Sensor and Transmitter 2Martek's life'sDHA(TM) Now Available in Protein-free Powder 2Martek's life'sDHA(TM) Now Available in Protein-free Powder 3
(Date:3/12/2015)... , March 12, 2015 IriTech, a ... a member of the Texas Instruments Design Network, announced ... has demonstrated its IriShield USB MK2120U device during ... facility for pension distribution. The iris ... to be marketed in India ...
(Date:3/12/2015)... VIEW, Calif. , March 12, 2015 /PRNewswire/ ... with Complimentary Registration here: http://bit.ly/1G7Os0L . SPEAKERS: ... Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... in order to compete in several different markets ... market is currently witnessing an uptrend. ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
Breaking Biology News(10 mins):Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
... are reporting the first evidence from human research that ... antioxidants and other so-called phytochemicals improve memory. They ... clinical trials to determine whether blueberries really deserve their ... the study appears in ACS, Journal of Agricultural ...
... jury could decide a man,s guilt through mind reading? What ... And what constitutes ,intent, to commit murder? These are just ... issue of WIREs Cognitive Science, the latest interdisciplinary project from ... first two years. In the article "Neurolaw," in ...
... who have identified brain networks damaged in Parkinson,s disease have ... before symptoms appear. And what,s more, parts of the network ... the brain. "We were surprised," said Chris Tang, ... Medical Research in Manhasset, NY, and an author of the ...
Cached Biology News:Mind reading, brain fingerprinting and the law 2Brain abnormalities in Parkinson's patients develop before symptoms occur 2
... Stem Cell Antibody Panels to its expanding ... Embryonic Stem Cell Marker Antibody Panel (Catalog ... phosphatase, Nanog, Oct-3/4, SSEA-1 and SSEA-4. The ... Plus (Catalog # SC009) contains antibodies against: ...
Epstein-Barr Virus (EBV) (EBNA-1)...
ECE-1 (H-60)...
Mouse HAI-1 Ectodomain MAb (Clone 199732)...
Biology Products: